Galmed’s Aramchol shows promise in overcoming gastrointestinal cancer drug resistance
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD
The data highlight sustained intraocular pressure (IOP) reduction, drop-free treatment outcomes, and strong visual performance
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
Revenue for the quarter rose 5.8% to Rs. 1,487 crore as compared to Rs. 1,406 crore in the corresponding quarter of the previous fiscal
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
With over two decades of extensive experience, Lal has established himself as a transformational leader in the FMCG and consumer goods sectors
Vitiligo, affecting over 90 per cent of patients in its non-segmental form, is characterized by symmetrical white patches on both sides of the body
Subscribe To Our Newsletter & Stay Updated